Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations

10.1016/j.drudis.2013.07.021

Saved in:
Bibliographic Details
Main Authors: Ho, H.K., Yeo, A.H.L., Kang, T.S., Chua, B.T.
Other Authors: PHARMACY
Format: Review
Published: 2014
Online Access:http://scholarbank.nus.edu.sg/handle/10635/106639
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-106639
record_format dspace
spelling sg-nus-scholar.10635-1066392023-10-26T21:17:05Z Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations Ho, H.K. Yeo, A.H.L. Kang, T.S. Chua, B.T. PHARMACY 10.1016/j.drudis.2013.07.021 Drug Discovery Today 19 1 51-62 DDTOF 2014-10-29T02:02:58Z 2014-10-29T02:02:58Z 2014-01 Review Ho, H.K., Yeo, A.H.L., Kang, T.S., Chua, B.T. (2014-01). Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations. Drug Discovery Today 19 (1) : 51-62. ScholarBank@NUS Repository. https://doi.org/10.1016/j.drudis.2013.07.021 13596446 http://scholarbank.nus.edu.sg/handle/10635/106639 000330147500007 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
description 10.1016/j.drudis.2013.07.021
author2 PHARMACY
author_facet PHARMACY
Ho, H.K.
Yeo, A.H.L.
Kang, T.S.
Chua, B.T.
format Review
author Ho, H.K.
Yeo, A.H.L.
Kang, T.S.
Chua, B.T.
spellingShingle Ho, H.K.
Yeo, A.H.L.
Kang, T.S.
Chua, B.T.
Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
author_sort Ho, H.K.
title Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
title_short Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
title_full Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
title_fullStr Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
title_full_unstemmed Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerations
title_sort current strategies for inhibiting fgfr activities in clinical applications: opportunities, challenges and toxicological considerations
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/106639
_version_ 1781788279585112064